Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients

被引:8
|
作者
Honge, Bo L. [1 ,2 ,3 ]
Andersen, Morten N. [4 ,5 ]
Jespersen, Sanne [2 ,3 ]
Medina, Candida [6 ]
Correira, Faustino G. [6 ]
Jakobsen, Martin R. [5 ]
Laursen, Alex [3 ]
Erikstrup, Christian [1 ]
Moller, Holger J. [4 ]
Wejse, Christian [2 ,3 ,7 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Immunol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau
[3] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark
[4] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark
[5] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[6] Minist Hlth, Natl HIV Programme, Bissau, Guinea Bissau
[7] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, GloHAU, Aarhus, Denmark
基金
美国国家卫生研究院;
关键词
HIV; HIV-1; HIV-2; AIDS; CRP; sCD163; Guinea-Bissau; Africa; GUINEA-BISSAU; CD163;
D O I
10.1097/QAI.0000000000000939
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The course of disease among HIV-2, HIV-1, and HIV-1/2 dually infected patients is different. We investigated the macrophage activation marker soluble CD163 (sCD163) dynamics in 212 HIV-1, HIV-2, and HIV-1/2 dually infected patients. There were no differences in sCD163 levels at baseline or during follow-up without antiretroviral therapy (ART). At follow-up on ART, median sCD163 levels were decreased for HIV-1-infected patients (P < 0.001), but not among HIV-2 (P = 0.093) or HIV-1/2 dually infected patients (P = 0.145). The larger decrease in sCD163 levels among HIV-1-infected patients during ART may indicate an HIV type-dependent differential effect of ART on macrophage activation during HIV infection.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [1] Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia
    van der Loeff, MFS
    Jaffar, S
    Aveika, AA
    Sabally, S
    Corrah, T
    Harding, E
    Alabi, A
    Bayang, A
    Ariyoshi, K
    Whittle, HC
    [J]. AIDS, 2002, 16 (13) : 1775 - 1783
  • [2] CLINICAL CORRELATIONS IN HIV-1 AND HIV-2 INFECTED PATIENTS
    MONTEIROGOILLA, M
    SOUSA, AP
    GALVAO, J
    YUEH, M
    MARQUESNEVES, C
    RIBERODASILVA, J
    [J]. VISION RESEARCH, 1995, 35 : 3211 - 3211
  • [3] HIV-1/HIV-2 SERONEGATIVITY IN HIV-1 SUBTYPE-O INFECTED PATIENTS
    LOUSSERTAJAKA, I
    BRUNVEZINET, F
    SIMON, F
    LY, TD
    CHAIX, ML
    SARAGOSTI, S
    COUROUCE, AM
    INGRAND, D
    [J]. LANCET, 1994, 343 (8910): : 1393 - 1394
  • [4] Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa
    Togun, Toyin
    Peterson, Ingrid
    Jaffar, Shabbar
    Oko, Francis
    Okomo, Uduak
    Peterson, Kevin
    Jaye, Assan
    [J]. AIDS RESEARCH AND THERAPY, 2011, 8
  • [5] Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa
    Toyin Togun
    Ingrid Peterson
    Shabbar Jaffar
    Francis Oko
    Uduak Okomo
    Kevin Peterson
    Assan Jaye
    [J]. AIDS Research and Therapy, 8
  • [6] Alterations of HELIOS, PLZF, and EOMES in NK cells from HIV-1, HIV-2, and dually HIV-1 and HIV-2 infected individuals
    Malone, D. F. G.
    Bachle, S. M.
    Buggert, M.
    Moll, M.
    Biague, A.
    Norrgren, H.
    Medstrand, P.
    Sandberg, J. K.
    Jansson, M.
    [J]. IMMUNOLOGY, 2014, 143 : 108 - 108
  • [7] Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off
    Jespersen, Sanne
    Honge, Bo Langhoff
    Esbjornsson, Joakim
    Medina, Candida
    Te, David da Silva
    Correira, Faustino Gomes
    Laursen, Alex Lund
    Ostergaard, Lars
    Andersen, Andreas
    Aaby, Peter
    Erikstrup, Christian
    Wejse, Christian
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (02) : 253 - 262
  • [8] Superinfection of an HIV-2 infected woman by HIV-1
    Huber, M.
    Boeni, J.
    Schuepbach, J.
    Guenthard, H.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S38 - S38
  • [9] Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis
    Prince, Puck D.
    Matser, Amy
    van Tienen, Carla
    Whittle, Hilton C.
    van der Loeff, Maarten F. Schim
    [J]. AIDS, 2014, 28 (04) : 549 - 558
  • [10] Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Cote D'Ivoire
    Koblavi-Dème, S
    Kestens, L
    Hanson, D
    Otten, RA
    Borget, MY
    Bilé, C
    Wiktor, SZ
    Roels, TH
    Chorba, T
    Nkengasong, JN
    [J]. AIDS, 2004, 18 (03) : 413 - 419